0000899243-20-029327.txt : 20201027 0000899243-20-029327.hdr.sgml : 20201027 20201027173116 ACCESSION NUMBER: 0000899243-20-029327 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201027 FILED AS OF DATE: 20201027 DATE AS OF CHANGE: 20201027 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: VINK PATRICK V.J.J. CENTRAL INDEX KEY: 0001557501 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38266 FILM NUMBER: 201265270 MAIL ADDRESS: STREET 1: ETZELSTRASSE 20 CITY: 8707 UETIKON AM SEE STATE: V8 ZIP: V8 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Spero Therapeutics, Inc. CENTRAL INDEX KEY: 0001701108 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 675 MASSACHUSETTS AVENUE STREET 2: 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 857-242-1600 MAIL ADDRESS: STREET 1: 675 MASSACHUSETTS AVENUE STREET 2: 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: Spero Therapeutics, LLC DATE OF NAME CHANGE: 20170316 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-10-27 0 0001701108 Spero Therapeutics, Inc. SPRO 0001557501 VINK PATRICK V.J.J. C/O SPERO THERAPEUTICS, INC. 675 MASSACHUSETTS AVENUE, 14TH FLOOR CAMBRIDGE MA 02139 1 0 0 0 Stock Option (right to buy) 13.52 2020-10-27 4 A 0 7500 0.00 A 2030-10-27 Common Stock 7500 7500 D The shares underlying this option will vest and become exercisable in full on October 27, 2021 subject to the Reporting Person's continued service as a director through the vesting date. /s/ Patrick V.J.J. Vink 2020-10-27